Drug Interaction Report

Acarbose and Pindolol: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Pindolol

Visken®
+

Acarbose

Prandase® Precose Precose®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 135 documented Acarbose interactions, 64 are rated moderate — including this one.
At a glance Effects may be stronger Effects may be weaker Some uncertainty
The Bottom Line
Pindolol can hide the racing-heart warning sign of low blood sugar and shift your glucose control while on acarbose, but more frequent monitoring and dose adjustments by your care team handle this well. Keep taking both as prescribed and watch for sweating or shakiness.

Pindolol is a beta-blocker (often used for blood pressure), and acarbose helps lower blood sugar in diabetes. When they are taken together, your blood sugar can swing a bit higher or lower, and that is worth knowing about.

The bigger concern is that pindolol can hide some of the early warning signs of low blood sugar. Normally your heart races when your sugar drops, but a beta-blocker can quiet that signal. You may still feel sweaty or shaky, so those are good clues to watch for. The good news: your care team can manage this easily by checking your sugars a little more often and adjusting doses if needed. Keep taking both exactly as prescribed and talk with your pharmacist or doctor.

Interaction: Nonselective beta-blocker (pindolol) plus acarbose may alter glycemic control (hypo- or hyperglycemia) and blunt adrenergic warning signs of hypoglycemia. Neither is a prodrug; this is a pharmacodynamic interaction, not CYP-mediated.

  • Direction: Beta blockade can potentiate hypoglycemia and impair glucose recovery; hyperglycemia possible, especially in HF/diabetes.
  • Masked symptoms: Tachycardia is suppressed; diaphoresis and dizziness usually preserved.
  • Onset: Delayed. Evidence: Probable. Severity: Moderate.
  • Management: Increase glucose self-monitoring; individualize antidiabetic dose. If pindolol is discontinued, watch for loss of glycemic control.
Onset
delayed
Evidence
probable
Severity
Moderate

What happens

Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia

Interaction Deep Dive

When antidiabetic medications and beta-blockers are used together, the result may be either hypoglycemia or hyperglycemia, and the warning signs of hypoglycemia can be masked12. This masking can affect tachycardia, though other hypoglycemic manifestations such as dizziness and sweating remain unaffected6. Insulin-induced hypoglycemia may be intensified by nonselective beta-blockers, which can also impede the restoration of serum glucose. In individuals who have both heart failure and diabetes, hyperglycemia may deteriorate7. It may become necessary to monitor glucose more frequently or to modify the dose of the antidiabetic agent12. During combined use, watch carefully for hypoglycemic signs and symptoms, and should the beta-blocker be discontinued, monitor for a loss of glycemic control3.

Why it happens (mechanism)

Altered glucose metabolism and beta blockade

How to manage this interaction

This interaction is manageable, and you should keep taking both medications as prescribed unless your care team tells you otherwise.

  • Check your blood sugar more often so any highs or lows are caught early.
  • Know the signs of low blood sugar that pindolol does not mask, such as sweating and shakiness, since a racing heart may not be as noticeable.
  • Your doctor may adjust and individualize your diabetes medication dose based on your readings.
  • If your pindolol is ever stopped or changed, tell your team so they can watch for your sugar climbing.

Bring your glucose logs to appointments and ask your pharmacist any questions.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) In elderly diabetic patients receiving either insulin or sulfonylureas, the selection of antihypertensive agent had minimal impact on the risk of hypoglycemia; however, once other risk factors were accounted for, the lowest risk occurred with cardioselective beta blockers and the highest with non-cardioselective beta blockers, while the remaining antihypertensive agents produced intermediate outcomes (N=13,559) 4.

b) Beta blockers, unlike alpha blockade and ACE inhibitors, produced a worsening of long-term glycemic control in patients who had hypertension along with non-insulin dependent diabetes. Beta blockade also led to some unfavorable changes in the lipid profile. These effects were particularly evident with propranolol. Using an alpha blocker together with the beta blocker prevented the worsening attributable to beta blockade 5.

Common questions

Can I take Acarbose and Pindolol together?

Pindolol can hide the racing-heart warning sign of low blood sugar and shift your glucose control while on acarbose, but more frequent monitoring and dose adjustments by your care team handle this well. Keep taking both as prescribed and watch for sweating or shakiness. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Acarbose and Pindolol interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How is the Acarbose and Pindolol interaction managed?

This interaction is manageable, and you should keep taking both medications as prescribed unless your care team tells you otherwise. Check your blood sugar more often so any highs or lows are caught early. Know the signs of low blood sugar that pindolol does not mask, such as sweating and shakiness, since a racing heart may not be as noticeable. Your doctor may adjust and individualize your diabet… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Acarbose or Pindolol need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (7)

  1. Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
  2. Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  3. Product Information: Glynase(R) PresTab(R) oral micronized tablets, glyburide oral micronized tablets. Pharmacia & Upjohn Co (per FDA), New York, NY, 2013. DailyMed
  4. Shorr RI, Ray WA, Daugherty JR, et al: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA 1997; 278:40-43. DOI
  5. Whitcroft IA, Thomas JM, Rawsthorne A, et al: Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics. Horm Metab Res Suppl 1990; 22:42-46.
  6. Product Information: TENORMIN(R) oral tablets, atenolol oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2012. DailyMed
  7. Product Information: COREG CR(R) extended-release oral capsules, carvedilol phosphate extended-release oral capsules. GlaxoSmithKline, Research Triangle Park, NC, 2011. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.